DRUG · Unmapped registry intervention
Tamoxifen 10 mg Tablet
Find medicine records ·
Find other trials using this name
Clinical trial
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT06033092
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Intermittent caloric restriction
Find medicine records ·
Find other trials using this name
BEHAVIORAL · Unmapped registry intervention
Step counter Device
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedLow Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
BRCA Mutationunresolved
PALB2 Gene Mutationunresolved
ATM Gene Mutationunresolved
CHEK2 Gene Mutationunresolved
CDH1 Gene Mutationunresolved
RAD51C Gene Mutationunresolved
RAD51D Gene Mutationunresolved
Interventions
Sponsors & collaborators
European Institute of Oncologylead sponsor
Ente Ospedaliero Ospedali Gallieracollaborator
Istituto Oncologico Veneto IRCCScollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06033092 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.